Published in Arch Ophthalmol on June 01, 2003
Structural and biochemical aspects of keratan sulphate in the cornea. Cell Mol Life Sci (2010) 0.85
Laser-assisted in situ keratomileusis for correction of astigmatism and increasing contact lens tolerance after penetrating keratoplasty. Korean J Ophthalmol (2014) 0.76
Viscocanalostomy in rhesus monkeys. Arch Ophthalmol (2004) 2.04
Effectively implementing evidence-based medicine. Ophthalmology (2013) 1.95
Baseline donor characteristics in the Cornea Donor Study. Cornea (2005) 1.92
Depth-dependent cohesive tensile strength in human donor corneas: implications for refractive surgery. J Refract Surg (2008) 1.58
Toxic anterior segment syndrome. J Cataract Refract Surg (2006) 1.53
Slitlamp, specular, and light microscopic findings of human donor corneas after laser-assisted in situ keratomileusis. Arch Ophthalmol (2004) 1.46
Histopathologic examination of failed grafts in descemet's stripping with automated endothelial keratoplasty. Ophthalmology (2009) 1.43
Histopathology of radial keratotomy. Arch Ophthalmol (2005) 1.39
Registration of clinical trials. Arch Ophthalmol (2005) 1.39
Not for your eyes: information concealed through publication bias. Am J Ophthalmol (2008) 1.39
How to ensure our readers' trust: the proper attribution of authors and contributors. Am J Ophthalmol (2008) 1.38
Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer. Mol Pharmacol (2007) 1.35
Cohesive tensile strength of human LASIK wounds with histologic, ultrastructural, and clinical correlations. J Refract Surg (2005) 1.33
Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival. Cancer Res (2004) 1.32
Cataract surgery in patients with nanophthalmos: results and complications. J Cataract Refract Surg (2004) 1.32
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology (2002) 1.29
Prostaglandin-induced hair growth. Surv Ophthalmol (2002) 1.28
Association between vitamin D and age-related macular degeneration in the Third National Health and Nutrition Examination Survey, 1988 through 1994. Arch Ophthalmol (2007) 1.28
Mechanism and clinical significance of prostaglandin-induced iris pigmentation. Surv Ophthalmol (2002) 1.24
Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin Cancer Res (2007) 1.21
Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. Invest Ophthalmol Vis Sci (2010) 1.17
Ocular tuberculosis. Arch Ophthalmol (2005) 1.12
Corneal ectasia after LASIK despite low preoperative risk: tomographic and biomechanical findings in the unoperated, stable, fellow eye. J Refract Surg (2010) 1.11
Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells. Invest Ophthalmol Vis Sci (2006) 1.08
A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea (2012) 1.07
Cataract surgery in patients with prior refractive surgery. Curr Opin Ophthalmol (2003) 1.06
Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma. Invest Ophthalmol Vis Sci (2003) 1.03
Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction. Invest Ophthalmol Vis Sci (2008) 0.99
Peripheral keratitis following laser in situ keratomileusis. J Refract Surg (2003) 0.98
Fibrin glue for the prevention of epithelial ingrowth after laser in situ keratomileusis. J Cataract Refract Surg (2003) 0.97
Interface fluid syndrome in laser in situ keratomileusis after complicated trabeculectomy. J Cataract Refract Surg (2006) 0.96
Dry eye disease in patients after cataract surgery. Cornea (2008) 0.96
Twice-daily, preservative-free ketorolac 0.45% for treatment of inflammation and pain after cataract surgery. Am J Ophthalmol (2010) 0.92
Advanced keratomalacia with descemetocele in an infant with cystic fibrosis. Arch Ophthalmol (2005) 0.92
Toxicity and dose-response studies of 1-alpha hydroxyvitamin D2 in LH-beta-tag transgenic mice. Ophthalmology (2003) 0.90
Toxicity and dose-response studies of 1alpha-hydroxyvitamin D2 in a retinoblastoma xenograft model. Arch Ophthalmol (2002) 0.89
Drug-induced cicatrising granulomatous conjunctivitis. Br J Ophthalmol (2007) 0.89
Lasik enhancements: a comparison of lifting to recutting the flap. Ophthalmology (2002) 0.89
The Open Access initiative in scientific and biomedical publishing: fourth in the series on editorship. Am J Ophthalmol (2005) 0.88
Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma. Arch Ophthalmol (2002) 0.87
To lift or recut: changing trends in LASIK enhancement. J Cataract Refract Surg (2003) 0.87
Recurrent corneal erosions causing bacterial keratitis. Optometry (2008) 0.86
Aspergillus infection of the orbital apex masquerading as Tolosa-Hunt syndrome. Arch Ophthalmol (2007) 0.85
Spontaneous uveal amelanotic melanoma in transgenic Tyr-RAS+ Ink4a/Arf-/- mice. Arch Ophthalmol (2005) 0.85
Resveratrol metabolites do not elicit early pro-apoptotic mechanisms in neuroblastoma cells. J Agric Food Chem (2011) 0.84
Effect of latanoprost on hair growth in the bald scalp of the stump-tailed macacque: a pilot study. Acta Derm Venereol (2002) 0.84
Histopathological analysis of post-laser-assisted in situ keratomileusis corneal ectasia with intrastromal corneal ring segments. Arch Ophthalmol (2005) 0.83
Nomogram considerations with the Technolas 217A for treatment of myopia. J Refract Surg (2003) 0.82
Refractive surgery after corneal transplantation. Curr Opin Ophthalmol (2005) 0.82
Shaken adult syndrome: report of 2 cases. JAMA Ophthalmol (2013) 0.82
Enhancing intraocular lens outcome precision: an evaluation of axial length determinations, keratometry, and IOL formulas. Ophthalmol Clin North Am (2006) 0.82
Financially efficient cataract surgery in today's healthcare environment. Curr Opin Ophthalmol (2015) 0.82
Eyelid fibrous hamartoma with conjunctival angioma in an infant. Arch Ophthalmol (2007) 0.81
Modern management of astigmatism. Int Ophthalmol Clin (2013) 0.81
Sympathetic ophthalmia following evisceration: a rare case. Ophthal Plast Reconstr Surg (2005) 0.80
Vitelliform retinopathy in metastatic cutaneous melanoma with choroidal involvement. Arch Ophthalmol (2011) 0.80
Changes in contrast sensitivity after Artisan lens implantation for high myopia. Ophthalmology (2005) 0.80
Surgical removal of an atypical macular epiretinal membrane in neurofibromatosis type 2: clinicopathologic correlation and visual outcome. Arch Ophthalmol (2012) 0.80
The editorial process for medical journals: I. Introduction of a series and discussion of the responsibilities of editors, authors, and reviewers. Am J Ophthalmol (2003) 0.79
Correlation between epithelial ingrowth and basement membrane remodeling in human corneas after laser-assisted in situ keratomileusis. Arch Ophthalmol (2010) 0.79
A clinicopathologic case study of two patients with pediatric orbital IgG4-related disease. Orbit (2013) 0.79
Chronic pain after Intacs implantation. J Cataract Refract Surg (2006) 0.79
Ophthalmic education: where have we come from, and where are we going? Am J Ophthalmol (2003) 0.79
Suppression of thrombospondin-1 expression during uveal melanoma progression and its potential therapeutic utility. Arch Ophthalmol (2012) 0.78
Microsatellite instability and alterations of mismatch repair protein expression in choroidal melanomas. Arch Ophthalmol (2005) 0.78
Transitional cell carcinoma of the lacrimal sac presenting with bloody tears. JAMA Ophthalmol (2013) 0.78
Evaluation of neuroprotective qualities of brimonidine during LASIK. Ophthalmology (2003) 0.78
1 alpha-Hydroxyvitamin D2 inhibits growth of human neuroblastoma. J Neurooncol (2007) 0.78
Ocular trauma resulting in enucleation: A 12-year experience from a large regional institution. WMJ (2014) 0.78
A synergetic screening approach with companion effector for combination therapy: application to retinoblastoma. PLoS One (2013) 0.78
Noninflammatory flap edema after laser in situ keratomileusis associated with asymmetrical preoperative corneal pachymetry. J Cataract Refract Surg (2005) 0.78
Keratan sulfate and chondroitin/dermatan sulfate in maximally recovered hypocellular stromal interface scars of postmortem human LASIK corneas. Invest Ophthalmol Vis Sci (2006) 0.78
Alcohol and mechanical scraping for epithelial ingrowth following laser in situ keratomileusis. J Refract Surg (2005) 0.78
Histopathologic characteristics of choroidal melanoma in eyes enucleated after iodine 125 brachytherapy in the collaborative ocular melanoma study. Arch Ophthalmol (2008) 0.78
Postoperative visual acuity in patients with fuchs dystrophy undergoing descemet membrane-stripping automated endothelial keratoplasty: correlation with the severity of histologic changes. Arch Ophthalmol (2012) 0.78
The expanding role of phakic intraocular lenses-not just for the rare patient anymore. J Refract Surg (2011) 0.77
Treating ocular surface disease: new agents in development. Clin Ophthalmol (2011) 0.77
Lichen simplex chronicus of the conjunctiva. JAMA Ophthalmol (2013) 0.77
Toxicity and dose-response studies of 1 alpha-hydroxyvitamin D2 in LH beta-Tag transgenic mice. Trans Am Ophthalmol Soc (2002) 0.77
Correlations of long-term matrix metalloproteinase localization in human corneas after successful laser-assisted in situ keratomileusis with minor complications at the flap margin. Arch Ophthalmol (2008) 0.76
A microscopy study of the structural features of post-LASIK human corneas. PLoS One (2013) 0.76
Pathologic findings in postmortem corneas after successful laser in situ keratomileusis. Cornea (2005) 0.76
Loss of vision after laser in situ keratomileusis. Eye Contact Lens (2003) 0.76
Long-term survival in a patient with uveal melanoma and liver metastasis. Arch Ophthalmol (2004) 0.76
Outcomes of photorefractive keratectomy enhancement after LASIK. J Refract Surg (2014) 0.76
Variability of subjective classifications of corneal topography maps from LASIK candidates. J Refract Surg (2013) 0.76
Use of the artificial iris implant in patients with aniridia. Optometry (2005) 0.75
The importance of the refractive aspects of cataract surgery. Am J Ophthalmol (2005) 0.75
Uveal melanoma masquerading as pigment dispersion glaucoma. Arch Ophthalmol (2008) 0.75
Sebaceous cell carcinoma of the eyelid: a rapidly enlarging lesion with massive xanthogranulomatous inflammation. Ophthal Plast Reconstr Surg (2010) 0.75
Evaluation of the antitumor effects of Herpes simplex virus lacking ribonucleotide reductase in a murine retinoblastoma model. Curr Eye Res (2004) 0.75
Melanoma, vitiligo, and uveitis. Ophthalmology (2010) 0.75
The occurrence and proposed significance of Schnabel cavernous degeneration in uveal melanoma. JAMA Ophthalmol (2014) 0.75
Hydration with saline decreases toxicity of mice injected with calcitriol in preclinical studies. J Environ Pathol Toxicol Oncol (2013) 0.75
Bilateral Primary Mucinous Carcinoma of the Eyelid. Ophthal Plast Reconstr Surg (2016) 0.75
Sponge use and mydriatic medications. J Cataract Refract Surg (2004) 0.75
Interface fluid after LASIK. Ophthalmology (2003) 0.75
Ectasia after refractive surgery. Ophthalmology (2008) 0.75
Penetrating keratoplasty and keratolimbal allograft transplantation for corneal perforations associated with the ectodermal dysplasia syndrome. Cornea (2003) 0.75